Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial
Open accessThe DOI matches its Crossref record; 43 of the 47 references it cites were found in a registry or an index.
Abstract
Background: Hashimoto disease is a chronic autoimmune thyroiditis. Despite adequate hormone substitution, some patients have persistent symptoms that may be the result of immunologic pathophysiology. Objective: To determine whether thyroidectomy improves symptoms in patients with Hashimoto thyroiditis who still have symptoms despite having normal thyroid gland function while receiving medical therapy. Design: Randomized trial. (ClinicalTrials.gov: NCT02319538). Setting: Secondary care hospital in Norway. Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum antithyroid peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL. Intervention: Total thyroidectomy or medical management with hormone substitution to secure euthyroid status in both groups. Measurements: The primary outcome was general health score on the Short Form-36 Health Survey (SF-36) at 18 months. Secondary outcomes were adverse effects of surgery, the other 7 SF-36 subscores, fatigue questionnaire scores, and serum anti-TPO antibody titers at 6, 12, and 18 months. Results: During follow-up, only the surgical group demonstrated improvement: Mean general health score increased from 38 to 64 points, for a between-group difference of 29 points (95% CI, 22 to 35 points) at 18 months. Fatigue score decreased from 23 to 14 points, for a between-group difference of 9.3 points (CI, 7.4 to 11.2 points). Chronic fatigue frequency decreased from 82% to 35%, for a between-group difference of 39 percentage points (CI, 23 to 53 percentage points). Median serum anti-TPO antibody titers decreased from 2232 to 152 IU/mL, for a between-group difference of 1148 IU/mL (CI, 1080 to 1304 IU/mL). In multivariable regression analyses, the adjusted treatment effects remained similar to the unadjusted effects. Limitation: Results are applicable only to a subgroup of patients with Hashimoto disease, and follow-up was limited to 18 months. Conclusion: Total thyroidectomy improved health-related quality of life and fatigue, whereas medical therapy did not. This improvement, along with concomitant elimination of serum anti-TPO antibodies, may elucidate disease mechanisms. Primary Funding Source: Telemark Hospital.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this study of patients with elevated antibody titers, patients who underwent thyroidectomy and had a decline in thyroid peroxidase antibodies reported improved general health on the Short Form-36 Health Survey (SF-36), compared with patients who did not undergo thyroidectomy.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [69]
In the citing paper
“One recent study suggested that elevated thyroid peroxidase antibodies might be associated with dissatisfaction with LT4 therapy (69).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [69]
In the citing paper
“A randomised controlled trial of 150 individuals with persistent symptoms of hypothyroidism and high TPO-Ab titres, despite restoration of euthyroidism, showed that thyroidectomy improved quality of life and reduced TPO-Ab titres.171”
From Hypothyroidism (2024) · cites this paper as [171]
In the citing paper
“After 1.5 years, median TPO-Ab values were reduced from 2,232 to 152 kU/L in the surgical group, and from 2,052 to 1,300 kU/L in the medical group [69].”
From T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) · cites this paper as [69]
In the citing paper
“LT4-treated patients with persistent symptoms despite a normal TSH and high TPO-Ab were randomized to receive total thyroidectomy or continuation of LT4 treatment; QoL and fatigue improved after total thyroidectomy.”
From T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) · cites this paper as [69]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · cited 2×
“5 SD, which equals 11 points assuming an SD of 22, as reported in the literature (22, 23).”
BackgroundDevelopment of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 3×
“2 (12) — — Range, y 18–74 — 18–79 — — Sex (male/female), n/n 5/68 0 7/67 0 — Mean BMI (SD), kg/m(2) 25 (7) 6 26 (8) 6 — Cardiovascular disease, n (%) 11 (15) 0 23 (31) 1 — Nonthyroid autoimmune disease, n (%)† 19 (26) 0 18 (24) 1 — Psychiatric disorder, n (%)‡ 10 (14) 0 14 (19) 1 — Other disease, n (%)§ 16 (22) 0 16 (…”
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,605
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Interval estimation for the difference between independent proportions: comparison of eleven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<873::aid-sim779>3.0.co;2-i · Cited by 1,851 · cited 1×
“For the dichotomous outcome variable chronic fatigue, 95% CIs for the proportions and the differences in proportions were calculated at each time point by using the Wilson score method (25).”
MethodHiggins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134 · cited 2×
“Mean quality-of-life scores (SD) General health 37 (21) 1 39 (20) 0 — Physical functioning 69 (21) 0 65 (19) 0 — Role physical 19 (30) 0 25 (32) 0 — Bodily pain 42 (21) 0 40 (22) 0 — Vitality 22 (15) 0 25 (20) 0 — Social functioning 46 (27) 0 49 (26) 0 — Role emotional 35 (39) 0 42 (39) 0 — Mental health 57 (20) 0 58…”
BackgroundA CONTROLLED TRIAL OF ARTHROSCOPIC SURGERY FOR OSTEOARTHRITIS OF THE KNEE
Ruce, J. B., Imberly, K., Etersen, A. J. P., Enke, T. E. J. M., Rody, A., Uykendall, D. A. H. K., Ohn, J., Shton, C. A. M. A., & Ray, E. P. W. (2002) · Cited by 1,087
Hashimoto thyroiditis: Clinical and diagnostic criteria
Caturegli, P., De Remigis, A., & Rose, N. R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.007 · Cited by 1,057 · cited 2×
“H disease, first described in 1912 (1) and recognized as an autoimmune disease decades later (2), is the most prevalent autoimmune disease worldwide (3, 4).”
Background
Research works printed but not linked: 2
- Hashimoto H, 1912, Arch Klin Chir, 219
- Weetman AP, 1982, Clin Exp Immunol, 48, 196
Cited by
Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy
Ragusa, F., Fallahi, P., Elia, G., Gonnella, D., Paparo, S. R., Giusti, C., Churilov, L. P., Ferrari, S. M., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101367 · Cited by 655
“Futhermore interestingly, median serum AbTPO titers decreased from 2232 to 152 IU/mL (61).”
An update on the pathogenesis of Hashimoto’s thyroiditis.
Weetman, A. P. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01477-1 · Cited by 258
Hashimoto thyroiditis: an evidence-based guide: etiology, diagnosis and treatment
Klubo-Gwiezdzinska, J., & Wartofsky, L. (2022) · Polish Archives of Internal Medicine · doi:10.20452/pamw.16222 · Cited by 207
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
“One recent study suggested that elevated thyroid peroxidase antibodies might be associated with dissatisfaction with LT4 therapy (69).”
Primary hypothyroidism and quality of life
Hegedüs, L., Bianco, A. C., Jonklaas, J., Pearce, S. H., Weetman, A. P., & Perros, P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00625-8 · Cited by 144
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Tywanek, E., Michalak, A., Świrska, J., & Zwolak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094703 · Cited by 115
“Researchers demonstrated the improvement in the health-related quality of life and reduction of fatigue in the group of patients after thyroidectomy; positive effects were explained with the elimination of serum anti-TPO antibodies [132].”
BackgroundJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Perros, P., Van Der Feltz‐Cornelis, C., Papini, E., Nagy, E. V., Weetman, A. P., & Hegedüs, L. (2023) · Clinical Endocrinology · doi:10.1111/cen.14473 · Cited by 65
Hypothyroidism: The difficulty in attributing symptoms to their underlying cause
Jansen, H. I., Boelen, A., Heijboer, A. C., Bruinstroop, E., & Fliers, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130661 · Cited by 63
“However, there was no control group for the surgical intervention (36).”
BackgroundGroenewegen, K. L., Mooij, C. F., & van Trotsenburg, A. S. P. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100101 · Cited by 49
“SF-36 general health score, fatigue score and chronic fatigue frequency improved only in the patients who underwent thyroidectomy [57].”
BackgroundBrain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Samuels, M. H., & Bernstein, L. J. (2022) · Thyroid · doi:10.1089/thy.2022.0139 · Cited by 64
“TPOAbs decreased and fatigue and HRQoL improved markedly only in thyroidectomy group (62).”
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
Ferrari, S. M., Ragusa, F., Elia, G., Paparo, S. R., Mazzi, V., Baldini, E., Benvenga, S., Antonelli, A., & Fallahi, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.750380 · Cited by 75
“A recent randomized trial suggested that total thyroidectomy can ameliorate quality of life and fatigue in these patients (Guldvog et al., 2019).”
BackgroundInfluentialLi, J., Huang, Q., Sun, S., Zhou, K., Wang, X., Pan, K., Zhang, Y., Wang, Y., Han, Q., Si, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78938-7 · Cited by 56
Schoormans, D., Wijnberg, L., Haak, H. R., Husson, O., & Mols, F. (2020) · Head & Neck · doi:10.1002/hed.26290 · Cited by 40
T4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
Physical fatigability and muscle pain in patients with Hashimoto thyroiditis
Jordan, B., Uer, O., Buchholz, T., Spens, A., & Zierz, S. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10394-5 · Cited by 39
“1 3 surgery, correlating also with decline in ab and improvement in health-related quality of life (SF 36) [12, 23].”
BackgroundResultInfluentialQin, X., Luo, J., Ma, J., Cao, X., Zhao, J., Jiang, J., Zhang, Y., Zeng, L., & Fan, L. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000725 · Cited by 22
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Wiersinga, W. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.501 · Cited by 21
Janicki, Ł., Patel, A., Jendrzejewski, J., & Hellmann, A. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1273498 · Cited by 20
A Literature Review of Painful Hashimoto Thyroiditis: 70 Published Cases in the Past 70 Years
Peng, C. C., Chang, R. H., Pennant, M., Huang, H., & Munir, K. M. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz008 · Cited by 18
“75) 39 (37-48) 35 (23-48) Country Japan 26/70 (37.”
BackgroundMemeh, K., Ruhle, B. C., Vaghaiwalla, T. M., Kaplan, E. L., Keutgen, X. M., & Angelos, P. (2020) · Surgery · doi:10.1016/j.surg.2020.03.028 · Cited by 19
Casula, S., Ettleson, M. D., & Bianco, A. C. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.003 · Cited by 21
Iron: Not Just a Passive Bystander in AITD
Szklarz, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · Nutrients · doi:10.3390/nu14214682 · Cited by 19
Wirth, U., von Ahnen, T., Hampel, J., Schardey, J., Busch, P., Schardey, H. M., & Schopf, S. K. (2021) · Surgical Endoscopy · doi:10.1007/s00464-021-08361-w · Cited by 15
Tagoe, C. E., Wang, W., Wang, S., & Barbour, K. E. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211035199 · Cited by 18
Lee, Y. K., Lee, D.-E., Hwangbo, Y., Lee, Y. J., Kim, H. C., & Lee, E. K. (2020) · Thyroid · doi:10.1089/thy.2019.0709 · Cited by 16
Thyroidectomy for euthyroid patients with Hashimoto disease and persisting symptoms
Hoff, G., Bernklev, T., Johnsen, L., Reitsma, L., Sina, D., Lauzike, A., Gibbs, C., Carlsen, E., Lende, T. H., Narvestad, J. K., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-1593 · Cited by 12
Self-citationJonklaas, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934003 · Cited by 13
The Year in Surgical Thyroidology
Yeh, M. W. (2019) · Thyroid · doi:10.1089/thy.2019.0767 · Cited by 11
“In August 2019, Guldvog et al. published a prospective randomized trail comparing total thyroidectomy and standard medical management for 150 euthyroid patients with Hashimoto’s thy-roiditis and persistent constitutional symptoms (14).”
Clinical features and treatment efficacy for IgG4-related thyroiditis
Han, X., Zhang, P., Li, J., Liu, Z., Lu, H., Luo, X., Pan, B., Lian, X., Zeng, X., Zhang, W., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01942-x · Cited by 11
Quality of Life After Thyroidectomy for Hashimoto Disease in Patients With Persistent Symptoms
Thatipamala, P., Noel, J. E., & Orloff, L. A. (2020) · Ear Nose & Throat Journal · doi:10.1177/0145561320967332 · Cited by 10
“Recent clinical trial data, however, have shown that thyroidectomy may be a beneficial option in patients with persistent symptoms and extremely elevated TPO Ab levels.(10) In the current study, we present health-related and diseasespecific quality of life outcomes in patients with HT undergoing thyroidectomy specific…”
BackgroundHoff, G. S., Bernklev, T., Johnsen, L., Reitsma, L. C., Sina, D., Lauzike, A., Gibbs, C., Lende, T. H., Narvestad, J. K., Kildahl, R., et al. (2024) · Journal of Thyroid Research · doi:10.1155/2024/5518720 · Cited by 10
Self-citationZhang, H., Tong, W., Zeng, W., Luo, H., Zhang, L., Feng, J., Xiao, Y., & Wang, G. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1627787 · Cited by 19
Koehler, V. F., & Bojunga, J. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1258-5674 · Cited by 15
“[31] Guldvog I, Reitsma LC, Johnsen L et al.”
Hidalgo, J., Lincango-Naranjo, E. P., Cordova-Madera, S., Ruiz-Arellanos, K., Wenczenovicz, C., Ponce, O. J., Álvarez‐Villalobos, N. A., Rao, A., Ospina, N. S., Maraka, S., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03816-1 · Cited by 11
Luo, J., Zhou, L., Sun, A., Min, Y., Lin, Y., & Han, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35114 · Cited by 8
“…with HT who are euthyroid with LT-4 medical treatment still have persistent symptoms, such as chronic fatigue, weakness, nervousness, irritability, frequent mood swings, and impaired sexual activity, indicating that supplementing thyroid hormones is not the fundamental treatment for HT [105].”
BackgroundBenvenga, S., Antonelli, A., Fallahi, P., Bonanno, C., Rodolico, C., & Guarneri, F. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100274 · Cited by 10
Vaghaiwalla, T. M., DeTrolio, V. R., Saghira, C., Akcin, M., Chen, C., McGillicuddy, C. M., & Lew, J. I. (2024) · Surgery · doi:10.1016/j.surg.2024.09.050 · Cited by 7
Bakos, B., Solymosi, T., Szili, B., Vincze, Á., Mészáros, S., Stempler, M., Armos, R., Kiss, A., Bakos, A., Szücs, N., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01962-9 · Cited by 8
“In one randomized study thyroidectomy improved QoL in Hashimoto’s patients [17].”
Genetic and epigenetic markers in Hashimoto's thyroiditis (Review)
Abdalrahman, S., Smail, H. O., & Shallal, A. F. (2025) · International Journal of Epigenetics · doi:10.3892/ije.2025.24 · Cited by 7
“…8‑12 weeks following the start of treatment should be scheduled, and patients can monitor their symptoms and TsH levels by frequently visiting their physician. patients and physicians should work together to ensure the successful management of the disease and to maintain the patient's health (36).”
InfluentialShared Decisionmaking in the Treatment of Hypothyroidism
Bianco, A. C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15228 · Cited by 7
“This has provided the rationale for clinical trails of selenium [13] and for thyroidectomy, which improved symptoms [14, 15].”
Acupuncture treatment for Hashimoto's thyroiditis: An exploratory randomized controlled trial
Shan-ze, W. A. N. G., Yang, C., Zeng, W., Tian, H., Du, S., & Zhao, J. (2024) · Integrative Medicine Research · doi:10.1016/j.imr.2024.101023 · Cited by 5
Angell, T. E. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.178-181 · Cited by 5
The Year in Medical Thyroidology Review: Current Challenges and Future Directions
Busaidy, N. L. (2019) · Thyroid · doi:10.1089/thy.2019.0792 · Cited by 6
“randomized patients with symptomatic Hashimoto’s thyroiditis to surgery versus medical management (3,4).”
BackgroundHashimoto’s thyroiditis as an autoimmune disorder
Yilmaz, Y., Aydemir, E., & Ayaz, F. (2025) · Discover Medicine · doi:10.1007/s44337-025-00479-3 · Cited by 8
Meng, X., Hao, R., Liu, K., Zhang, P., An, C., Zhang, Y., Li, H., Wu, B., Li, M., Yu, X., et al. (2025) · Autoimmunity · doi:10.1080/08916934.2025.2601015 · Cited by 4
The American Thyroid Association Multidisciplinary Consensus Statement on Ambulatory Thyroid Surgery
Noureldine, S. I., Seib, C. D., Buczek, E. P., David, M., Dhingra, J. K., Ganly, I., James, B. C., Khoury, N., Modi, B. P., Parangi, S., et al. (2026) · Thyroid · doi:10.1177/10507256261442596 · Cited by 6
“28 When planning thyroid surgery in a reoperative fi eld, whether due to previous thyroid, parathyroid, airway, or anterior approach spinal operations, consideration should be given to the anticipated risks of nerve injury and hypopara-thyroidism when determining the feasibility of same-day…”
Advances in the Understanding of Genomic Links Between Thyroid Dysfunction and Psychiatric Disorders
Nygaard, B. (2022) · Thyroid · doi:10.1089/thy.2022.0686 · Cited by 4
“9 12 The authors state that almost all hypo-and hyperthyroid patients have an autoimmune disease.”
Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13214 · Cited by 4
More trials for the unhappy hypothyroid patient on thyroxine: a clinician’s perspective
Welborn, T. A. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.04.010 · Cited by 5
(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs93.12081216 · Cited by 3
“[14] on the mechanisms of the effectiveness of HT surgical treatment.”
BackgroundQuality of Life After Thyroidectomy in Patients With Hashimoto's Disease: A Systematic Review
HoSang, K. M., Lawler, S., Nace, T., & Kuo, L. E. Y. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.07.056 · Cited by 2
Sim, M., Tan, E., Liew, H., Tan, A. W. K., & Li, H. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.10.041 · Cited by 2
Tagoe, C. E., Wang, W., & Barbour, K. E. (2023) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x231154984 · Cited by 3
Outcomes of thyroidectomy in symptomatic, euthyroid Hashimoto's patients: a case control study
Serrao-Brown, H. G., Saadi, A., Wong, J., Papachristos, A., Sywak, M. S., & Sidhu, S. B. (2024) · ANZ Journal of Surgery · doi:10.1111/ans.19155 · Cited by 2
“9 In recent years, there is a growing body of research demonstrating the role of total thyroidectomy (TT) for patients with refractory HT. 5,10,11 However, there is a paucity of data regarding improvements in QoL.”
Wen, X., Zhou, S., Li, W., Li, H., Song, X., Mao, Y., Li, Z., Chen, G., Peng, X., & Wu, P. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-82626-x · Cited by 2
Jonklaas, J. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2492789 · Cited by 2
“Although thyr-oidectomy for patients with hypothyroidism, persistent symptoms, and elevated thyroid peroxidase antibodies does reduce symptoms in conjunction with reduced thyroid peroxidase antibodies [31], this is clearly not a universal solution.”
Outcomes of Preoperative Medical Therapy for Thyroidectomy in Autoimmune Thyroid Disease
Braafladt, S. M., Baumgartner, T. C., Allison, H. R., Blumenthaler, A. N., Ritter, H. E., Mariash, C. N., Elfenbein, D. M., & McDow, A. D. (2023) · Journal of Surgical Research · doi:10.1016/j.jss.2023.11.021 · Cited by 2
Тиреоидит Хашимото — терапевтическая или хирургическая проблема? (Обзор литературы)
SHIDLOVSKYI, V. O., Shidlovskyi, А. V., Sheremet, M. I., & Твердохліб, В. В. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.3.2020.205274 · Cited by 2
Wolffenbuttel, B. H. R., Wouters, H. J. C. M., Kobold, A. C. M., Roozendaal, C., & van der Klauw, M. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1550125/v1 · Cited by 2
One sip of water with LT-4 supplementation—a key to euthyroidism in Hashimoto’s thyroiditis
Schnedl, W. J., Michaelis, S., Mangge, H., & Enko, D. (2024) · Endocrine · doi:10.1007/s12020-024-03829-w · Cited by 1
“However, LT-4 has a narrow therapeutic window and up to 50% of patients fail to maintain a desired serum TSH level within the normal range [8].”
BackgroundÖzkan, S., Taş, S., Kumbasar, S., Gümüş, M., & Kaynak, B. A. (2025) · CRANIO® · doi:10.1080/08869634.2025.2499300 · Cited by 2
“The prevalence of Hashimoto’s thyroiditis (HT), which is the most prevalent form of thyroiditis and is an autoimmune disorder [12], was reported higher in patients with TMDs compared to healthy controls [10].”
Trost, S. U., & Radulescu, A. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag074 · Cited by 1
“Normalization of antithyroid antibodies in a group of women with HT undergoing total thyroidectomy was associated with resolution of severe residual hypothyroid symptoms and also indicates the role of normalization of thyroid antibodies [13].”
Overview of Thyroid Disease in Children and Adolescents
Zwaveling‐Soonawala, N., & van Trotsenburg, A. S. P. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_3-1 · Cited by 1
Okuno, Y., Mukai, K., Tamura, Y., Hayakawa, T., Fukuhara, A., & Shimomura, I. (2024) · Case Reports in Endocrinology · doi:10.1155/2024/2524019 · Cited by 1
“TPOAb levels also decrease to nearly normal levels after total thyroidectomy in Hashimoto ’ s thyroiditis [15].”
BackgroundClinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Preexisting Thyroid Autoimmunity Is Associated with Increased Thyroid Cancer Risk
Udyavar, N. R., & Morris, L. F. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.250-252 · Cited by 1
“A 2019 study demonstrated improved quality of life after thyroidectomy in patients with anti-TPO >1000 IU/ml while on thyroid hormone replacement (9).”
Depression Is Associated with a History of Thyroid Surgery
Toft, D. J. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.54-57
“Two studies have shown an improved quality of life among patients with Hashimoto’s hypothyroidism following thyroidectomy; however, in the earlier report, there was no improvement in those who were euthyroid prior to surgery (6,7).”
Wémeau, J.-L. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.02.001
SHIDLOVSKYI, V. O., SHIDLOVSKYI, V. O., Sheremet, M. I., & Твердохліб, В. В. (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-2-43
“[12] щодо механізмів ефективності хірургічного лікування ТХ.”
Autoimmunerkrankungen der Schilddrüse
Zieren, H. U. (2021) · CME · doi:10.1007/s11298-020-1872-3
64 脳卒中片麻痺における,音刺激後の片脚挙上動作反応時間と歩行能力の関連性(神経系理学療法IV)
福井, 瑞., 久保田, 健., 伊藤, 俊., & 隈元, 庸. (2005) · Journal of the Japanese Physical Therapy Association
Hashimoto-Thyreoiditis: Nach aktueller Symptomatik und Befunden therapieren
Zieren, H. U. (2021) · Deutsches Ärzteblatt · doi:10.3238/persimmun.2021.09.17.03
Analysis of complications of surgical treatment of patients with autoimmune thyroiditis
Shidlovskyi, O. V., & SHIDLOVSKYI, V. O. (2021) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2021-2-19
Diagnosis and Management of Thyroiditis: Hashimoto, de Quervain, Riedel
Russell, M. D., & Chiang, J. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_4
Total Thyroidectomy in Hashimoto Thyroiditis: are We in the Right Path?
Sarathi, V., & Dhananjaya, M. S. (2022) · Indian Journal of Surgery · doi:10.1007/s12262-022-03374-8
“Although in a previous randomized-controlled study, thyroidectomy improved the quality of life and fatigue score in HT patients with persistent symptoms and markedly elevated anti-TPO levels (> 1000 IU/mL), experts seek high-quality data with longer follow-up before considering thyroidectomy for the claimed benefits i…”
7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
Rayes, N. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-63317-5_10
43/w mit Schmerzen zervikal und Globusgefühl
Mintziras, I., & Holzer, K. (2023) · Die Chirurgie · doi:10.1007/s00104-023-01876-z
“Neben der konservativen Therapie kommt in beiden Fällen eine definitive Therapie im Sinne einer Thyreoidektomie nach Nutzen-RisikoAbwägung in Betracht.”
InfluentialThyroidectomy for Pain Alleviation in Hashimoto\'s Thyroiditis: Case Report and Review of Literature
Sinha, N., Ghosh, R., Garg, S., Kashyap, S., & Dandekar, M. (2023) · International Journal of Head and Neck Surgery · doi:10.5005/jp-journals-10001-1547
Shareef, S. A., Allami, R. H., & Al-Ezzy, R. M. (2024) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1325/1/012024 · Cited by 1
A Novel Approach to the Levothyroxine Absorption Test Using Only Two Free T4 Measurements
Barrera, C. A. B., Fragozo-Ramos, M. C., & Builes-Montaño, C. E. (2024) · ScienceBank · doi:10.61340/hfqg5777
Overview of Thyroid Disease in Children and Adolescents
Zwaveling‐Soonawala, N., & van Trotsenburg, A. S. P. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_3 · Cited by 1
Düzen, İ. V., Tülüce, S. Y., Ozturk, S. S., Savcılıoğlu, M. D., Göksülük, H., Altunbaş, G., Kaplan, M., Vuruşkan, E., Tabur, S., Sucu, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051705
“In a study, improvement in symptoms and a decrease in anti-TPO levels were observed following thyroidectomy in patients with HT whose symptoms had persisted despite becoming euthyroid with thyroid hormone replacement therapy [19].”
Hoff, G. S., Bernklev, T., Kvaløy, J. T., Gibbs, C., & Reitsma, L. C. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.007
Self-citationSotirović, J., Petrovic, M. G., Milojević, M., Baletić, N., Čukić, O., & Zaletel, I. V. (2025) · Vojnosanitetski pregled · doi:10.2298/vsp241029031s
Inflammatory biomarkers in Hashimoto’s thyroiditis: a comparative cross-sectional study
Deniz, M. S., & Coşkun, A. (2025) · Anatolian Current Medical Journal · doi:10.38053/acmj.1667024
Chronic Lymphocytic Thyroiditis Does Not Worsen Early Surgical Outcomes in Papillary Thyroid Cancer
Vaghaiwalla, T. M., Chang, J., DeTrolio, V. R., Saghira, C., Akcin, M., Chen, C., & Lew, J. I. (2025) · World Journal of Surgery · doi:10.1002/wjs.70012
Welborn, T. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1640663
Bednarczuk, T., Sugier, A., Attanasio, R., Nagy, E. V., Negro, R., Papini, E., Žarković, M., Akarsu, E., Alevizaki, M. K., Ayvaz, G., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1713814 · Cited by 1
Additional file 1 of Clinical features and treatment efficacy for IgG4-related thyroiditis
Han, X., Zhang, P., Li, J., Liu, Z., Lu, H., Luo, X., Pan, B., 连小兰, Zeng, X., Zhang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15032935
Imam, S. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-12937-6_11 · Cited by 1
Feng, X., Lyu, X., Gao, Y., Gao, X., & Gao, R. L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1827517
Yang, Y., Zhang, G., Yang, X., Wang, Y., Zhang, S., Wang, D. F., Wang, X., He, Z., Chen, H. H., Luo, Y., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c06778
Omdal, R., Grimstad, T. B., Jonsson, G., Kvaløy, J. T., Gibbs, C., Reitsma, L. C., Bernklev, T., & Hoff, G. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1862441
“Consistent with this, our previous study of women undergoing thyroidectomy for benign goiter with underlying Hashimoto ’ s thyroiditis showed that removal of the thyroid gland led to a marked and sustained improvement in fatigue and HRQOL, largely abolishing the excess fatigue burden (12).”
Self-citationHashimoto's thyroiditis: two decades on
Duntas, L. H., & Effraimidis, G. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00189-0
Immune Dysregulation and Precision Therapeutics in Hypothyroidism and Hyperthyroidism
Haq, F., Alam, W., & Ryu, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018451
Metadata
- Authors
- Guldvog, I., Reitsma, L. C., Johnsen, L., Lauzike, A., Gibbs, C., Carlsen, E., Lende, T. H., Narvestad, J. K., Omdal, R., Kvaløy, J. T., Hoff, G., Bernklev, T., & Søiland, H.
- Affiliations
- Telemark Hospital (NO)
- Stavanger University Hospital (NO)
- University of Oslo (NO)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-04-02
- Volume
- 170
- Issue
- 7
- Pages
- 453-464
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2922355726
- Cited by
- 99
- References
- 47
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 15 · 2023: 10 · 2022: 11 · 2021: 18 · 2020: 12 · 2019: 6
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Annals of Internal Medicine
- Topics
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Keywords
- Hashimoto's thyroiditis, total thyroidectomy, euthyroid patients, persistent symptoms, thyroid peroxidase antibodies, health-related quality of life, fatigue, hormone replacement therapy, autoimmune thyroiditis, surgical versus medical management, SF-36 Health Survey, postoperative adverse reactions, disease mechanisms, chronic fatigue syndrome, thyroid autoimmunity
- MeSH terms
- Patient Reported Outcome Measures, Adolescent, Adult, Aged, Antibodies, Drug Therapy, Combination, Fatigue, Female, Follow-Up Studies, Humans, Iodide Peroxidase, Male, Middle Aged, Postoperative Complications, Quality of Life, Thyroid Gland, Thyroidectomy, Thyroxine, Triiodothyronine, Hormone Replacement Therapy, Hashimoto Disease, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.